Table 2

Plasma phospholipids fatty acid levels after EPA + DHA and placebo supplementation in 12 men with type 2 diabetes
Placebo EPA + DHA Difference P
Fatty acid levels (%)
LA 19.9 (3.6) 19.3 (2.9) −0.6 0.09
ALA 0.21 (0.09) 0.19 (0.11) −0.02 0.85
DGLA 3.82 (1.57) 2.87 (0.65) −0.95 0.001
AA 9.40 (2.05) 7.97 (1.37) −1.43 0.0005
EPA 1.00 (0.93) 3.53 (1.65) 2.53 0.0005
DPA 1.03 (0.34) 1.25 (0.26) 0.22 0.0005
DHA 2.96 (1.15) 4.43 (1.26) 1.47 0.0005

Data are expressed as median and interquartile range in parentheses. P values were calculated using Wilcoxon matched-pairs signed-rank tests. Abbreviations: AA, arachidonic acid; ALA, alpha-linolenic acid; DGLA, dihomo-γ-linoleic acid; DHA, docosahexaenoic acid; DPA, docosapentaenoic acid; EPA, eicosapentaenoic acid; LA, linoleic acid; PUFA, polyunsaturated fatty acids.

Labonté et al.

Labonté et al. Nutrition Journal 2013 12:98   doi:10.1186/1475-2891-12-98

Open Data